Aceto Corporation
Pharmaceutical firm reports fourth quarter net income up 36%
Published in Healthcare Mergers, Acquisitions and Ventures Week, October 9th, 2004
Fourth quarter financial highlights include:
1) net sales grew 12% to $76.5 million;
2) gross profit margin increased to 17.1% from 16.2%;
3) operating income rose 28% to $3.3 million; and
4) net income was up 36% to $3.3 million, or $0.20 per diluted share, from $2.4 million or $0.15 per diluted share.
5) Income, before the cumulative effect of a non-cash accounting change of $1.9 million last year, grew 38% to $13.1 million or$0.81 per diluted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Option Care, Inc.
Home infusion therapy company provides 2004 financial results - APT Therapeutics, Inc.
Pharmaceutical firm secures seed funding of $1.6M - Abgenix, Inc.
Pharmaceutical firm appoints H. Ward Wolff as chief financial officer - Able Laboratories, Inc.
Generic pharmaceutical firm announces management appointments - Aceto Corporation
Pharmaceutical firm reports best year ever for sales, profits - Alfacell Corporation
Biotech firm's shares to trade on NASDAQ SmallCap market - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
